You are here

  • Home
  • Archive
  • Volume 101, Issue Suppl 1
  • G95 The Drooling Reduction Intervention (DRI) trial: Is hyoscine or glycopyrronium more effective and acceptable for the treatment of drooling in children with neurodisability?

Article metrics

Article menu
Download PDFPDF
British Paediatric Neurology Association and British Academy of Childhood Disability
G95 The Drooling Reduction Intervention (DRI) trial: Is hyoscine or glycopyrronium more effective and acceptable for the treatment of drooling in children with neurodisability?

 

Online download statistics by month:

Online download statistics by month: April 2016 to March 2024

AbstractFullPdf
Apr 2016401
May 20163001
Jun 201624028
Jul 201634014
Aug 20161905
Sep 20163701
Oct 20162402
Nov 20163304
Dec 20161202
Jan 20172305
Feb 20171100
Mar 20172102
Apr 20171100
May 20171200
Jun 20172505
Jul 20173002
Aug 20172803
Sep 20171801
Oct 20171800
Nov 20177807
Dec 20174605
Jan 20183000
Feb 20181602
Mar 20182602
Apr 20181601
May 20183000
Jun 20181401
Jul 20182401
Aug 20182202
Sep 2018602
Oct 2018800
Nov 20182400
Dec 20181401
Jan 2019900
Feb 20191501
Mar 2019202
Apr 2019200
May 2019200
Jun 2019400
Jul 2019500
Aug 2019201
Sep 2019200
Oct 20193602
Nov 20192602
Dec 2019501
Jan 20201000
Feb 20202001
Mar 2020100
Apr 2020200
May 20201000
Jun 2020900
Jul 2020400
Aug 2020200
Sep 20201400
Oct 2020800
Nov 20201000
Dec 2020200
Jan 20211001
Feb 20212200
Mar 2021400
Apr 2021401
May 2021100
Jun 2021100
Aug 2021001
Sep 2021100
Oct 2021200
Nov 2021700
Dec 20211200
Jan 20221500
Feb 2022200
Apr 2022500
May 2022600
Jun 2022200
Jul 20221600
Aug 20221001
Sep 20221201
Oct 2022800
Nov 20221000
Dec 20222001
Jan 20231100
Feb 2023800
Mar 20231000
Apr 2023500
May 2023903
Jun 2023103
Jul 20231100
Aug 2023200
Sep 2023400
Oct 2023400
Nov 2023600
Dec 20231900
Jan 2024200
Feb 2024200
Mar 20242200
Total12560122